Clinical TrialsSearch results
Number of results: 245
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Randomized controlled trial of capecitabine comparing 5-days-on/2-days-off regimen with 2-weeks-on/1-week-off regimen as adjuvant chemotherapy for colorectal cancer
(RCT of capecitabine 5-days-on/2-days-off or 2-weeks-on/1-week-off regimen for colorectal cancer)
- Colorectal cancer
- Yokoyama Shozo
- 2019-09-11
Other
- Docetaxel plus Ramucirumab with pegylated granulocyte-colony stimulating factor support for elderly patients with advanced non-small cell lung cancer: A multicenter prospective single arm phase II study (WJOG9416L)
- non-small cell lung cancer
- Hata Akito
- 2019-03-30
Other
- ESOX trial
- adenocarcinoma of the esophagogastric junction
- Watanabe Masayuki
- 2019-03-26
Other
- SOX-D2 study
- Gastric Cancer
- Sano Takeshi
- 2019-03-26
Recruiting
- Establishment of standard treatment for pancreatic ductal adenocarcinoma with peritoneal metastasis
- Invasive ductal adenocarcinoma
- Satoi Sohei
- 2019-03-26
Completed
- A phase I study of osimertinib with bevacizumab and randomized phase II study of osimertinib with or without bevacizumab in EGFR mutated, T790M positive patients who had progressed EGFR-TKIs. (WJOG8715L)
- Lung Cancer
- Teraoka Shunsuke
- 2019-03-26
Completed
- APISJ Study
- Parkinson's disease
- Takahashi Makio
- 2019-03-26
Completed
- A randomized phase II study comparing nivolumab with the combination of CBDCA and PEM for EGFR mutants NSCLC acquired resistance to EGFR-TKI from causes other than T790M (WJOG8515L)
- Lung Cancer
- Hayashi Hidetoshi
- 2019-03-18
Completed
- CapeOX Study
- gastric cancer
- Yamaguchi Kensei
- 2019-03-18
Completed
- prevention of post-ERCP pancreatitis by placement of 4Fr prophylactic pancreatic duct stent
- biliary duct disease
- Kitano Masayuki
- 2019-03-18